These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20525895)

  • 1. Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction.
    Gutzeit C; Raftery MJ; Peiser M; Tischer KB; Ulrich M; Eberhardt M; Stockfleth E; Giese T; Sauerbrei A; Morita CT; Schönrich G
    J Immunol; 2010 Jul; 185(1):488-97. PubMed ID: 20525895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
    Moffat JF; Zerboni L; Kinchington PR; Grose C; Kaneshima H; Arvin AM
    J Virol; 1998 Feb; 72(2):965-74. PubMed ID: 9444989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
    Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
    Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.
    Trannoy E; Berger R; Holländer G; Bailleux F; Heimendinger P; Vuillier D; Creusvaux H
    Vaccine; 2000 Feb; 18(16):1700-6. PubMed ID: 10689152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular studies of the Oka varicella vaccine.
    Quinlivan M; Breuer J; Schmid DS
    Expert Rev Vaccines; 2011 Sep; 10(9):1321-36. PubMed ID: 21919621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of human fetal dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine.
    Somekh E; Levin MJ
    J Med Virol; 1993 Jul; 40(3):241-3. PubMed ID: 8394874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A booster administration of the OKA/SK strain causes fatal disseminated varicella in an immunocompetent child.
    Kang HM; Kang KR; Kim YJ; Kang JH; Lee SY
    J Med Virol; 2023 Sep; 95(9):e29108. PubMed ID: 37715715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older.
    Berger R; Trannoy E; Holländer G; Bailleux F; Rudin C; Creusvaux H
    J Infect Dis; 1998 Nov; 178 Suppl 1():S99-103. PubMed ID: 9852985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of wild-type varicella-zoster strains from India and the Oka vaccine strain using a VZV open reading frame - 62 based PCR-RFLP technique.
    Kaushik KS; Lahiri KK; Kapila K; Kumar S; Gupta RM; Karade S
    Braz J Infect Dis; 2008 Aug; 12(4):313-5. PubMed ID: 19030732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis.
    Takayama M; Takayama N
    J Clin Virol; 2004 Feb; 29(2):113-9. PubMed ID: 14747030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulation of the Innate Immune Response by Varicella Zoster Virus.
    Gerada C; Campbell TM; Kennedy JJ; McSharry BP; Steain M; Slobedman B; Abendroth A
    Front Immunol; 2020; 11():1. PubMed ID: 32038653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Varicella-zoster virus (VZV)].
    Kanai K; Yamada S; Inoue N
    Uirusu; 2010 Dec; 60(2):197-207. PubMed ID: 21488333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
    Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characterization analysis of gM, gL genes of varicella zoster virus in six provinces of China].
    Mou JJ; Qi MY; Li CS; Zheng HY; Chen M; Zhou JH; He JL; Xu WW; Xu ST; Xu XG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):419-423. PubMed ID: 29614611
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis.
    Mori C; Takahara R; Toriyama T; Nagai T; Takahashi M; Yamanishi K
    J Infect Dis; 1998 Jul; 178(1):35-8. PubMed ID: 9652420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
    Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
    J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
    van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
    J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella-zoster virus isolates, but not the vaccine strain OKA, induce sensitivity to alpha-1 and beta-1 adrenergic stimulation of sensory neurones in culture.
    Schmidt M; Kress M; Heinemann S; Fickenscher H
    J Med Virol; 2003; 70 Suppl 1():S82-9. PubMed ID: 12627494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Herpes zoster after varicella-zoster vaccination].
    Fahlbusch M; Wesselmann U; Lehmann P
    Hautarzt; 2013 Feb; 64(2):107-9. PubMed ID: 23358727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.